Proto Labs Inc 4
4 · Proto Labs Inc · Filed Nov 1, 2013
Insider Transaction Report
Form 4
Proto Labs IncPRLB
JUDD JOHN R
Chief Financial Officer
Transactions
- Sale
Common Stock
2013-10-31$73.43/sh−2,687$197,306→ 40,615 total - Sale
Common Stock
2013-10-31$75.90/sh−7,693$583,926→ 27,206 total - Exercise/Conversion
Common Stock
2013-10-31$20.07/sh+50,000$1,003,500→ 50,000 total - Sale
Common Stock
2013-10-31$78.07/sh−10,725$837,310→ 12,405 total - Sale
Common Stock
2013-10-31$78.87/sh−2,405$189,676→ 10,000 total - Sale
Common Stock
2013-10-31$80.00/sh−10,000$800,000→ 0 total - Sale
Common Stock
2013-10-31$74.48/sh−6,698$498,888→ 43,302 total - Sale
Common Stock
2013-10-31$74.83/sh−5,716$427,717→ 34,899 total - Sale
Common Stock
2013-10-31$76.89/sh−4,076$313,387→ 23,130 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-10-31−50,000→ 75,000 totalExercise: $20.07Exp: 2021-06-22→ Common Stock (50,000 underlying)
Footnotes (9)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person.
- [F2]Reflects the weighted average price of 6,698 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $72.025 to $73.010 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Reflects the weighted average price of 2,687 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $73.07 to $73.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Reflects the weighted average price of 5,716 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $74.38 to $75.30 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Reflects the weighted average price of 7,693 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $75.4095 to $76.4075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]Reflects the weighted average price of 4,076 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $76.48 to $77.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F7]Reflects the weighted average price of 10,725 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $77.50 to $78.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F8]Reflects the weighted average price of 2,405 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on October 31, 2013 with sale prices ranging from $78.5675 to $79.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F9]The option vests as one-third of the shares beginning on June 22, 2012.